0001415889-23-012418.txt : 20230818 0001415889-23-012418.hdr.sgml : 20230818 20230818204525 ACCESSION NUMBER: 0001415889-23-012418 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230816 FILED AS OF DATE: 20230818 DATE AS OF CHANGE: 20230818 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Russo Rene CENTRAL INDEX KEY: 0001722066 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40925 FILM NUMBER: 231187109 MAIL ADDRESS: STREET 1: C/O ARSANIS, INC. STREET 2: 890 WINTER STREET, SUITE 230 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xilio Therapeutics, Inc. CENTRAL INDEX KEY: 0001840233 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851623397 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-833-1027 MAIL ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4-08182023_080801.xml X0508 4 2023-08-16 0001840233 Xilio Therapeutics, Inc. XLO 0001722066 Russo Rene 828 WINTER STREET SUITE 300 WALTHAM MA 02451 true true false false CEO 0 Stock Option (right to buy) 2.785 2023-08-16 4 A 0 700000 0 A 2033-08-15 Common Stock 700000 700000 D The option award was granted on August 16, 2023 and shall vest with respect to 1/3 of the shares of common stock underlying the stock option on the first anniversary of the grant date and with respect to the remaining 2/3 of the shares of common stock underlying the stock option on the second anniversary of the grant date. /s/ Chris Frankenfield, Attorney-in-Fact 2023-08-18